Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | Jan 7, 2013 at 12:42 PM EST

Celgene Guidance Brings All-Time Highs… What Lies Ahead

ThinkstockCelgene Corporation (NASDAQ: CELG) has issued some long-term guidance which appears to be at the high-end of its previous range.…

Jon C. Ogg | Jan 7, 2013 at 10:43 AM EST

Biotech and BioHealth Top Stocks on the Move (ACHN, CBMX, DNDN, EXAS, ILMN, PPHM, VVUS)

ThinkstockThere are big movers in the market just about every day, and these movers often come from biotech and other…

Jon C. Ogg | Jan 4, 2013 at 5:42 AM EST

12 Stocks Expected to Rise by 50% to 100% (or More) in 2013 (AMRN, CRZO, CNDO, EMKR, ETRM, EXAS, GALE, MX, OEDV, REGI, SPWR, SGYP)

It may seem hard to believe, but some stocks are expected to rise by 50%, 100%, or even more over…

Jon C. Ogg | Jan 3, 2013 at 9:04 AM EST

Lou Gehrig’s Disease Drug Failure Crushes Biogen Idec

ThinkstockBiogen Idec Inc. (NASDAQ: BIIB) is living up to why we just said it is now an overvalued biotech stock for 2013.…

Jon C. Ogg | Dec 24, 2012 at 11:52 AM EST

Alexza FDA Approval: Coal in the Christmas Stocking?

ThinkstockAlexza Pharmaceuticals, Inc. (NASDAQ: ALXA) is seeing its shareholders get nothing but coal for Christmas this year. The stock is…

Jon C. Ogg | Dec 20, 2012 at 2:57 PM EST

How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)

Jon OggThe largest biotech stocks have been great performers in 2012. The question is whether that can be sustained in…

Jon C. Ogg | Dec 20, 2012 at 6:21 AM EST

Nine Big Expected Biotech Winners for 2013 (ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Thinkstock24/7 Wall St. is looking for the next great biotech stocks for 2013 after great gains have been seen in…

Jon C. Ogg | Dec 18, 2012 at 10:43 AM EST

Is There Finally a Winner in the Crowded Obesity Drug Market?

ThinkstockAccording to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are…

Jon C. Ogg | Dec 18, 2012 at 9:35 AM EST

Analyst: Biogen Idec Gains Are Done

ThinkstockBiogen Idec Inc. (NASDAQ: BIIB) has had a great 2012. Actually, it has had a hell of a year with a gain…

Jon C. Ogg | Dec 18, 2012 at 8:11 AM EST

J.P. Morgan Sees More Upside in Hospital Stocks (CYH, HCA, LPNT, THC, UHS, HMA, VHS)

ThinkstockJ.P. Morgan Chase & Co. (NYSE: JPM) has issued a research call that calls for some very large upside in…

Paul Ausick | Dec 14, 2012 at 11:54 AM EST

Drug Maker Staging a Comeback After Yesterday’s Debacle

ThinkstockDrug developer Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) watched its shares plummet 35% yesterday following a report that rheumatoid arthritis treatment…

Paul Ausick | Dec 14, 2012 at 8:09 AM EST

Amgen Shakes Things Up: Dividend Boost, New Chairman, Share Buybacks

ThinkstockBiotech giant Amgen Inc. (NASDAQ: AMGN) made a series of moves after markets closed last night that appear to add…

Jon C. Ogg | Dec 11, 2012 at 2:53 PM EST

Teva Fails To Impress At Its Investor Meeting, Restructuring Awaits

ThinkstockTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) is not getting any great warm welcome out of its 2012 investor meeting webcast.…

Jon C. Ogg | Dec 10, 2012 at 2:01 PM EST

J&J Gets Broader Use for Prostate Cancer Drug

ThinkstockJohnson & Johnson (NYSE: JNJ) may have an even larger winner with its prostate cancer drug called ZYTIGA. The Food…

Paul Ausick | Dec 7, 2012 at 9:21 AM EST

Amarin Takes on More Debt, Shares Suffer

ThinkstockBiopharmaceutical company Amarin Corp. PLC (NASDAQ: AMRN) announced after markets closed last night that it has received $100 million in…

1 … 309 310 311 312 313 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Celgene Guidance Brings All-Time Highs… What Lies Ahead

Biotech and BioHealth Top Stocks on the Move (ACHN, CBMX, DNDN, EXAS, ILMN, PPHM, VVUS)

12 Stocks Expected to Rise by 50% to 100% (or More) in 2013 (AMRN, CRZO, CNDO, EMKR, ETRM, EXAS, GALE, MX, OEDV, REGI, SPWR, SGYP)

Lou Gehrig’s Disease Drug Failure Crushes Biogen Idec

Alexza FDA Approval: Coal in the Christmas Stocking?

How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)

Nine Big Expected Biotech Winners for 2013 (ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Is There Finally a Winner in the Crowded Obesity Drug Market?

Analyst: Biogen Idec Gains Are Done

J.P. Morgan Sees More Upside in Hospital Stocks (CYH, HCA, LPNT, THC, UHS, HMA, VHS)

Drug Maker Staging a Comeback After Yesterday’s Debacle

Amgen Shakes Things Up: Dividend Boost, New Chairman, Share Buybacks

Teva Fails To Impress At Its Investor Meeting, Restructuring Awaits

J&J Gets Broader Use for Prostate Cancer Drug

Amarin Takes on More Debt, Shares Suffer

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Health and Healthcare Articles

All Health and Healthcare Articles

Celgene Guidance Brings All-Time Highs… What Lies Ahead

Biotech and BioHealth Top Stocks on the Move (ACHN, CBMX, DNDN, EXAS, ILMN, PPHM, VVUS)

12 Stocks Expected to Rise by 50% to 100% (or More) in 2013 (AMRN, CRZO, CNDO, EMKR, ETRM, EXAS, GALE, MX, OEDV, REGI, SPWR, SGYP)

Lou Gehrig’s Disease Drug Failure Crushes Biogen Idec

Alexza FDA Approval: Coal in the Christmas Stocking?

How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)

Nine Big Expected Biotech Winners for 2013 (ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Is There Finally a Winner in the Crowded Obesity Drug Market?

Analyst: Biogen Idec Gains Are Done

J.P. Morgan Sees More Upside in Hospital Stocks (CYH, HCA, LPNT, THC, UHS, HMA, VHS)

Drug Maker Staging a Comeback After Yesterday’s Debacle

Amgen Shakes Things Up: Dividend Boost, New Chairman, Share Buybacks

Teva Fails To Impress At Its Investor Meeting, Restructuring Awaits

J&J Gets Broader Use for Prostate Cancer Drug

Amarin Takes on More Debt, Shares Suffer

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up